# Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19

> **NCT04472013** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 40 (actual)

## Conditions studied

- COVID-19 Disease

## Interventions

- **OTHER:** Data collection from lumbar puncture
- **OTHER:** Data collection from blood draw
- **OTHER:** CNS magnetic resonance imaging (MRI) imaging
- **OTHER:** Microscopy of defined brain regions on autopsy specimens

## Key facts

- **NCT ID:** NCT04472013
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-12
- **Primary completion:** 2022-11-09
- **Final completion:** 2022-11-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04472013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04472013, "Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04472013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*